Nanosonics Limited (OTCMKTS:NNCSF) Short Interest Down 50.3% in August

Nanosonics Limited (OTCMKTS:NNCSF) saw a large decrease in short interest in August. As of August 31st, there was short interest totaling 126,777 shares, a decrease of 50.3% from the August 15th total of 254,902 shares. Based on an average daily trading volume, of 3,840 shares, the days-to-cover ratio is currently 33.0 days.

Nanosonics Price Performance

Shares of OTCMKTS:NNCSF traded up $0.09 during midday trading on Tuesday, reaching $2.02. 20,000 shares of the company’s stock were exchanged, compared to its average volume of 2,589. The company’s 50 day simple moving average is $2.20 and its two-hundred day simple moving average is $2.35. Nanosonics has a 12 month low of $1.93 and a 12 month high of $3.06.

Nanosonics Company Profile

Nanosonics Limited is an Australia‐based medical technology company specializing in infection prevention solutions for the healthcare sector. Founded in 2001 and headquartered in Sydney, the company is best known for developing and commercializing its proprietary Trophon platform, which provides automated high‐level disinfection of ultrasound probes using sonically activated hydrogen peroxide vapor. Nanosonics holds numerous patents and regulatory approvals across multiple jurisdictions, positioning it as a leader in point‐of‐care decontamination.

The company’s flagship product, Trophon EPR, is designed to address the critical need for rapid, reliable disinfection of endocavity and surface ultrasound transducers.